Navigation Links
PI™ (Single Use Reloadable Stapler With Titanium Staples)

ProductsPI™ (Single Use Reloadable Stapler With Titanium Staples)
Company Autosuture
Item PI™ (Single Use Reloadable Stapler With Titanium Staples)
Features 
  • Linear stapler.
  • Reloadable.
  • Titanium staples.
  • In-line handle.
  • In-line handle design. Long narrow shaft allows for greater access and visibility in General, Thoracic and Colorectal procedures.
  • Instrument will not close if pin has not been seated properly, which ensures proper staple formation.
  • Slim anvil provides greater access and reduced dissection.
  • Jaws will not close with an empty/fired SULU, a partially or incorrectly loaded SULU, or without a SULU in the jaws, which prevents firing of staples unless a new cartridge with staples is properly loaded.
  • Convenient integral cutting guide provides precise transection if desired.
  • Spent Cartridge Indicator avoids confusion when determining if a cartridge has been fired or not.
  • 3 units per box.
    • Description Single Use reloadable linear stapler with titanium staples and in-line handle.

    The PI™ disposable stapler is designed for use in the resection or transection of normal, healthy internal tissues. The instrument places a double staggered row (or triple staggered row, when using the 30 VASCULAR cartridges) of titanium staples and is available in three staple line lengths. Three staple sizes are available to accommodate various tissue thicknesses. Each PI™ disposable stapler may be fired up to 4 times in a single patient procedure.
    Info Autosuture
    Customer Service: (800) 722-8772
    Web site: http://www.autosuture.com

    Related medicine products :

    1. PI™ (Single Use Loading Unit With Titanium Staples)
    2. Uric Acid (Uricase) (Single Reagent)
    3. Cholesterol (Single reagent)
    4. Dual Lock™ (Single And Double) Pivot Under-Table Shield
    5. SPRING-GRIP™ (Single Use Non-conductive Anchoring Devices)
    6. SURGINEEDLE™ (Single Use Pneumoperitoneum Needles)
    7. VERSAPORT™ Plus V2 (Single Use Converterless Trocar System)
    8. VERSAPORT™ Plus RPF (Single Use Converterless Trocar System)
    9. VERSAPORT™ Plus V2 RT (Single Use Obturators)
    10. VISIPORT™ Plus RPF (Single Use Optical Trocar With VERSAPORT™ Plus RPF Converterless Trocar Sleeve)
    11. BLUNTPORT Plus (Single Use Converterless 5 mm-12 mm Trocar System for Open Laparoscopy)
    With its wide orifice tip, the Finntip Wide is designed especially for pipetting fragile cell suspensions and macromolecules like genomic DNA. This tip eliminates the mechanical shearing that causes
    Finntips have been designed to optimize the accuracy and precision of Finnpipettes. The quality of our tip products is widely recognized by customers throughout the world. The Finntip range has been
    The BioCheck LH ELISA is intended for the quantitative determination of luteinizing hormone (LH) in human serum. This assay is useful in the diagnosis and treatment of gonadal dysfunction.
    ... hormone (LH) is a glycoprotein secreted by the an... the intact LH molecule is a noncovalently-linked ...lycoproteins all have homologous alpha-subunits, h...h LH and FSH production and secretion are stimulat...
    Medicine Products:
    (Date:11/22/2008)...is now happening for Medicare Advantage Plans. Th...and may also include Part D Prescription Drug Cove...instant quotes and applications. , ...08 -- MediGap Advisors is pleased to announce open...care Advantage Plans are health plan options that ...
    (Date:11/21/2008)...erm labor , , FRIDAY, Nov. 21 (HealthDay... that activates the uterine muscles for contractio...erapies for preterm labor. , The molecule pros...ace of these uterine muscle cells, keeping them re...archers from Dartmouth Medical School in New Hamps...
    (Date:11/21/2008)...niversity College of Medicine research team led by...er of regulation in the cell division cycle, which...cancer begins. , Wang, an assistant professor of...aid the findings will lead to an improved ability ... new drugs that kill cancer cells by inhibiting ce...
    (Date:11/21/2008)...Call/ -- Heska Corporation,(Nasdaq: HSKA ) toda...y of,Security Analysts, 12th Annual Biotech and S... 1177 Avenue of the Americas, 2nd Floor in New Yor...9:35 a.m. Eastern Time (7:35 a.m.,Mountain Time) ... weeks,following the presentation through a link ...
    Breaking Medicine News(10 mins):Health News:MediGap Advisors Announces Open Enrollment for Medicare Supplement Plans 2
    ...ows that men who are angry or hostile should find ...suffer from an irregular // heart rhythm called at... two upper chambers of the heart quiver instead of...l and form clots, increasing the chance for a stro...
    ...s women reduce their risk of birth defects. Now, n... patients alive.// Researchers say about 31,000 st...-related deaths may have been prevented each year ...lic acid lowers homocysteine levels. People with h...
    ...recent study, researchers say , 20 minutes on an e...ving chest pain // than even minimally invasive pr...dy, 101 men with stable coronary artery disease we...se program or intervention with a stent, which is ...
    ...recent study researchers say the estrogen pills do... to an increased risk of stroke.// Researchers sa...r to increase or decrease the risk of heart diseas...eved to do. Estrogen also does not appear to affec...
    Other Medicine News:
    (Date:11/13/2008)...ds Statins Cut Risk of Heart Attacks, Deaths, RES...ovascular Disease,is the leading cause of death am...eds of millions of dollars and causing untold suff...atal disease - even among those who,weren,t though...ions of people could cut their risk of a,heart att...
    (Date:11/12/2008)...mes D. Watson, Marilyn & James Simons and,Sherry L...., Nov. 12 J. Craig Ven...Venter Institute (JCVI), was,awarded the Double He...) on,November 6th at a gala event in New York City...ng with Dr. James D.,Watson for making each of the...
    (Date:11/12/2008)...Provides Reversible, High-level Platelet ...NEW ORLEANS and SOUTH SAN FRANCISCO, Calif., Nov. ...harmaceutical company developing innovative,drugs ...r and inflammatory,diseases, and cancer, today ann...8, the Company,s novel anti-platelet drug that dir...
    (Date:11/12/2008)... its kind shows no clinically meaningful, differen... nearsightedness, JACKSONVILLE, Fla., Nov. 12 /PR...t in clinically significant acceleration in the de...not cause relevant increases in axial,length or co...the,three-year study, the largest randomized trial...
    Breaking Medicine Technology:Seniors Can Be Heartened by New Study on Statins 2J. Craig Venter, Ph.D. Receives Double Helix Medal from Cold Spring Harbor Laboratory 2Portola Announces Data Showing Its Anti-Platelet Drug Inhibits Platelets in Clopidogrel (Plavix(R)) Non-Responders 2Portola Announces Data Showing Its Anti-Platelet Drug Inhibits Platelets in Clopidogrel (Plavix(R)) Non-Responders 3Soft Contact Lenses Do Not Lead to 'Myopic Creep' in Children, Study Shows 2Soft Contact Lenses Do Not Lead to 'Myopic Creep' in Children, Study Shows 3Chiltern Will Sponsor and Present at the 17th Annual Partnerships With CROs Meeting in Las Vegas April 14 16 2008 16386 1Chiltern Will Sponsor and Present at the 17th Annual Partnerships With CROs Meeting in Las Vegas April 14 16 2008 16386 2Obesity Costs U S Companies as Much as 2445 Billion a Year The Conference Board Reports 16384 1Obesity Costs U S Companies as Much as 2445 Billion a Year The Conference Board Reports 16384 2Obesity Costs U S Companies as Much as 2445 Billion a Year The Conference Board Reports 16384 3MedPage Today 28R 29 Selects iSEEK 28TM 29 to Improve Quality of Patient Care 16382 1MedPage Today 28R 29 Selects iSEEK 28TM 29 to Improve Quality of Patient Care 16382 2MedPage Today 28R 29 Selects iSEEK 28TM 29 to Improve Quality of Patient Care 16382 3MedPage Today 28R 29 Selects iSEEK 28TM 29 to Improve Quality of Patient Care 16382 4ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc 4499 1ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc 4499 2ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc 4499 3ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc 4499 4ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc 4499 5ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc 4499 6ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc 4499 7
    ...s intramuscular injection of peramivir for eight,d...s infection and,inhibited virus replication, suppo...ring a pandemic, MEMPHIS, Tenn., May 01, 2007 /PRN...r might offer humans significant protection,during...ording to,results of mouse studies conducted by in...
    ...ND, Sweden--(BUSINESS WIRE)--May 1, 2007 - Teva,Ph... today,announced that data from a 36-week, randomi...udy demonstrated that an oral 0.6 mg,dose of laqui...esonance imaging (MRI) disease activity by 38 perc...dition, there was a favorable,trend towards reduci...
    Other Medicine Technology:Peramivir Protects Mice From Lethal H5N1 Infection 2Peramivir Protects Mice From Lethal H5N1 Infection 3Laquinimod, a Novel Oral Compound, Showed Significant Reduction in,Disease Activity in Patients with Relapsing-Remitting Multiple,Sclerosis (RRMS) 2Laquinimod, a Novel Oral Compound, Showed Significant Reduction in,Disease Activity in Patients with Relapsing-Remitting Multiple,Sclerosis (RRMS) 3Laquinimod, a Novel Oral Compound, Showed Significant Reduction in,Disease Activity in Patients with Relapsing-Remitting Multiple,Sclerosis (RRMS) 4Laquinimod, a Novel Oral Compound, Showed Significant Reduction in,Disease Activity in Patients with Relapsing-Remitting Multiple,Sclerosis (RRMS) 5Laquinimod, a Novel Oral Compound, Showed Significant Reduction in,Disease Activity in Patients with Relapsing-Remitting Multiple,Sclerosis (RRMS) 6